Lacticaseibacillus rhamnosus R0011 and Improved Health-related Quality of Life

• Efficacy and safety of Lacticaseibacillus rhamnosus R0011 and Lactobacillus helveticus R0052 as an adjuvant for Helicobacter pylori eradication: a double-blind, randomized, placebo-controlled study.

  • 2023-09-14
  • RCT · n = 160
  • Frontiers in gastroenterology (Lausanne, Switzerland) 2
  • • Anya Kiattiweerasak
    • Natsuda Aumpan
    • Soonthorn Chonprasertsuk
    • Bubpha Pornthisarn
    • Sith Siramolpiwat
    • Patommatat Bhanthumkomol
    • Pongjarat Nunanan
    • Navapan Issariyakulkarn
    • Varocha Mahachai
    • Yoshio Yamaoka
    • Ratha-Korn Vilaichone

  • PubMed: 41821821
  • DOI: 10.3389/fgstr.2023.1245993

  4 Insights on

  • Improved Health-related Quality of Life

  • High evidence

  and higher SF-36 health-related quality-of-life scores (63.3 ± 10.2 vs. 57.3 ± 13.4, p=0.020) after treatment than the placebo group.

  Effect

  Beneficial

  Effect size

  Small

  Significant

  Yes